Merck KGaA (OTCMKTS:MKKGY) Posts Quarterly Earnings Results, Beats Expectations By $0.07 EPS

Merck KGaA (OTCMKTS:MKKGYGet Free Report) released its quarterly earnings results on Thursday. The company reported $0.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.47 by $0.07, Zacks reports. Merck KGaA had a return on equity of 10.41% and a net margin of 12.89%.

Merck KGaA Stock Performance

Shares of MKKGY stock traded up $0.72 during midday trading on Thursday, hitting $29.70. The company had a trading volume of 40,276 shares, compared to its average volume of 133,657. Merck KGaA has a 52-week low of $27.68 and a 52-week high of $39.17. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.33 and a quick ratio of 0.91. The company’s 50 day simple moving average is $29.21 and its 200 day simple moving average is $32.03. The stock has a market cap of $19.19 billion, a price-to-earnings ratio of 18.33, a PEG ratio of 2.05 and a beta of 0.98.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

See Also

Earnings History for Merck KGaA (OTCMKTS:MKKGY)

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.